I
Immunovant, Inc. (IMVT)
NMS – Real Time Price. Currency in USD
42.01
+1.08 (2.64%)
Market open: Aug 12, 2026, 2:37 PM EDT
40.93
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:40 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
42.01
+1.08 (2.64%)
Market open: Aug 12, 2026, 2:37 PM EDT
40.93
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:40 PM EDT
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren’s disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
| Name | Position |
|---|---|
| Dr. Eric Venker M.D., Pharm.D. | CEO & Director |
| Dr. Frank M. Torti M.B.A., M.D. | Executive Chairperson of the Board |
| Dr. Jay S. Stout M.S., Ph.D. | Chief Technology Officer |
| Mr. Christopher A. Van Tuyl Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Mr. Tiago M. Girao CPA | Chief Financial Officer |
| Ms. Becky Merlina | Senior VP & Global Head of Quality |
| Ms. Christine Blodgett | Senior Vice President of Human Resources |
| Ms. Melanie Gloria B.S.N. | Chief Operating Officer |
| Ms. Sheetal Patel M.B.A., M.D., M.S. | Senior Vice President of Clinical Development |
| Ms. Yan Zheng M.S., Ph.D. | Senior Vice President of Biostatistics, Programming & Data Management |
| Date | Type | Document |
|---|---|---|
| 2026-08-06 | 8-K | imvt-20260806.htm |
| 2026-08-06 | 10-Q | imvt-20260630.htm |
| 2026-07-22 | DEFA14A | defa14aadditionalmaterials.htm |
| 2026-05-20 | 8-K | imvt-20260520.htm |
| 2026-05-20 | 10-K | imvt-20260331.htm |
| 2026-02-06 | 8-K | imvt-20260206.htm |
| 2026-02-06 | 10-Q | imvt-20251231.htm |
| 2025-12-12 | 8-K | d68980d8k.htm |
| 2025-12-11 | 8-K | d760155d8k.htm |
| 2025-11-21 | 8-K | imvt-20251121.htm |